Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(1)

Adalimumab, etanercept, infliximab

1 trial

phase_4

university-of-padova

1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01237262Phase 4Unknown

Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy

Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.Moderate to Severe Psoriasis.

Studychair

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.1 Moderate to Severe Psoriasis1

Affiliations

University of Padova

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

4 similar investigators found

John Koo, MD

UCSF Psoriasis and Skin Treatment Center, Department of Dermatology, University of California, San Francisco

2 trials

Shared therapeutic areas:

Moderate to Severe Psoriasis

Similarity Score15%

Patrick Natta, M.D.

Sponsor GmbH

1 trials

Shared therapeutic areas:

Moderate to Severe Psoriasis

Similarity Score15%

Daiana Licu, MD

Merck Serono International SA

1 trials

Shared therapeutic areas:

Moderate to Severe Psoriasis

Similarity Score15%

Manuel Uribe, MD

AbbVie

1 trials

Shared therapeutic areas:

Moderate to Severe Psoriasis

Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01237262Phase 4StudyChair

Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy

Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.Moderate to Severe Psoriasis.

Unknown

All 1 trials loaded